74 related articles for article (PubMed ID: 21940330)
1. Surgical modalities for gastric carcinoma with concurrent portal hypertension: a retrospective study.
Xu Q; Gu L; Luo M; Wu ZY
Hepatogastroenterology; 2011; 58(110-111):1632-7. PubMed ID: 21940330
[TBL] [Abstract][Full Text] [Related]
2. The effect of extended lymphadenectomy on survival in patients with gastric adenocarcinoma.
Volpe CM; Koo J; Miloro SM; Driscoll DL; Nava HR; Douglass HO
J Am Coll Surg; 1995 Jul; 181(1):56-64. PubMed ID: 7599772
[TBL] [Abstract][Full Text] [Related]
3. Total gastrectomy for gastric carcinoma.
Isgüder AS; Nazli O; Tansug T; Bozdag AD; Onal MA
Hepatogastroenterology; 2005; 52(61):302-4. PubMed ID: 15783055
[TBL] [Abstract][Full Text] [Related]
4. Outcomes and survival after laparoscopic gastrectomy for adenocarcinoma. Analysis on 65 patients operated on by conventional or robot-assisted minimal access procedures.
Pugliese R; Maggioni D; Sansonna F; Ferrari GC; Forgione A; Costanzi A; Magistro C; Pauna J; Di Lernia S; Citterio D; Brambilla C
Eur J Surg Oncol; 2009 Mar; 35(3):281-8. PubMed ID: 18342480
[TBL] [Abstract][Full Text] [Related]
5. [Multivariate prognostic analysis in gastric carcinoma patients after radical operation].
Zhan YQ; Sun XW; Li W; Chen YB; Xu L; Guan YX; Li YF; Xu DZ
Ai Zheng; 2005 May; 24(5):596-9. PubMed ID: 15890105
[TBL] [Abstract][Full Text] [Related]
6. Current concepts in gastric cancer surgery.
Schumacher IK; Hunsicker A; Youssef PS; Lorenz D
Saudi Med J; 2002 Jan; 23(1):62-8. PubMed ID: 11938366
[TBL] [Abstract][Full Text] [Related]
7. Prognostic benefit of extended radical lymphadenectomy for patients with gastric cancer.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Anticancer Res; 2000; 20(2B):1285-9. PubMed ID: 10810436
[TBL] [Abstract][Full Text] [Related]
8. Secular trends in the use, quality, and outcomes of gastrectomy for noncardia gastric cancer in the United States.
Le A; Berger D; Lau M; El-Serag HB
Ann Surg Oncol; 2007 Sep; 14(9):2519-27. PubMed ID: 17610016
[TBL] [Abstract][Full Text] [Related]
9. [Prognostic significance of tumor size in the survival of patients with advanced gastric carcinoma].
Díaz Plasencia JA; Yan-Quiroz EF; Burgos-Chávez OA; Santillán-Medina JP; Stewart-Vilela Guillén E; Rojas-Vergara AM
Rev Gastroenterol Peru; 2001; 21(1):21-9. PubMed ID: 12170283
[TBL] [Abstract][Full Text] [Related]
10. [Morbidity and mortality in gastric cancer surgery--analysis of 468 cases with gastric adenocarcinoma].
Necula A; Vlad L; Iancu C; Munteanu D; Puia C; Bălă O; AlHajaar N; Pop F; Radu H; Osian G; Graur F; Furcea L; Stanca M; Molnar G; Mocanu L
Chirurgia (Bucur); 2008; 103(5):529-37. PubMed ID: 19260628
[TBL] [Abstract][Full Text] [Related]
11. [The surgical treatment of gastric carcinoma. Evolution in surgical technique and staging in a series of 194 patients].
Tersigni R; Alessandroni L; Baiano G; Mencacci R; Miceli M; Sadighi A; Sorgi G; Tremiterra S
Minerva Chir; 2004 Oct; 59(5):479-87. PubMed ID: 15494675
[TBL] [Abstract][Full Text] [Related]
12. Mortality and morbidity after resection for adenocarcinoma of the gastroesophageal junction: predictive factors.
Sauvanet A; Mariette C; Thomas P; Lozac'h P; Segol P; Tiret E; Delpero JR; Collet D; Leborgne J; Pradère B; Bourgeon A; Triboulet JP
J Am Coll Surg; 2005 Aug; 201(2):253-62. PubMed ID: 16038824
[TBL] [Abstract][Full Text] [Related]
13. Neither multiple tumors nor portal hypertension are surgical contraindications for hepatocellular carcinoma.
Ishizawa T; Hasegawa K; Aoki T; Takahashi M; Inoue Y; Sano K; Imamura H; Sugawara Y; Kokudo N; Makuuchi M
Gastroenterology; 2008 Jun; 134(7):1908-16. PubMed ID: 18549877
[TBL] [Abstract][Full Text] [Related]
14. The prognostic value of N-ratio in patients with gastric cancer: validation in a large, multicenter series.
Marchet A; Mocellin S; Ambrosi A; de Manzoni G; Di Leo A; Marrelli D; Roviello F; Morgagni P; Saragoni L; Natalini G; De Santis F; Baiocchi L; Coniglio A; Nitti D;
Eur J Surg Oncol; 2008 Feb; 34(2):159-65. PubMed ID: 17566691
[TBL] [Abstract][Full Text] [Related]
15. Does extended lymphadenectomy influence prognosis of gastric carcinoma after curative resection?
Ramacciato G; Aurello P; D'Angelo F; Cicchini C; Sternberg CN
Hepatogastroenterology; 2000; 47(35):1470-4. PubMed ID: 11100379
[TBL] [Abstract][Full Text] [Related]
16. [Five-year survival prognosis factors in patients with resectable advanced serosa exposed gastric carcinoma].
Yan-Quiroz EF; Díaz-Plasencia JA; Burgos-Chávez OA; Rojas-Vergara AM; Santillán-Medina J; Vilela-Guillén ES; Balmaceda-Fraselle T
Rev Gastroenterol Peru; 2003; 23(3):184-91. PubMed ID: 14532919
[TBL] [Abstract][Full Text] [Related]
17. Surgeon subspecialty as a factor in improving long-term outcomes for gastric cancer: Twenty years of experience in Korea.
Jang YJ; Park MS; Park SS; Kim JH; An H; Park SH; Kim SJ; Kim CS; Mok YJ
Arch Surg; 2010 Nov; 145(11):1091-6. PubMed ID: 21079098
[TBL] [Abstract][Full Text] [Related]
18. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
[TBL] [Abstract][Full Text] [Related]
19. Postoperative morbidity and mortality after gastrectomy for gastric carcinoma.
Ikeguchi M; Oka S; Gomyo Y; Tsujitani S; Maeta M; Kaibara N
Hepatogastroenterology; 2001; 48(41):1517-20. PubMed ID: 11677999
[TBL] [Abstract][Full Text] [Related]
20. Outcomes of surgical approaches for gastric cancer with portal hypertension.
Zhang ZY; Zhou ZQ; Zhou GW
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1348-52. PubMed ID: 25244416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
